Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Wisconsin, Madison
With
National Institutes of Health (NIH)
National Institute on Aging (NIA)
Age
55–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of probable AD
Has reliable and available caregiver to assist with medication and appointments
On a stable dose of cholinesterase inhibitor, or if unable to tolerate medication, patient has no plans to re-initiate cholinergic therapies while in the study
You may not be if
Current or recent use (\<6 months) of menopausal Hormone Replacement Therapy (HRT)
Current or recent use (\<4 months) or oral antibiotic therapy
Typical dietary intake of soy isoflavones \>5 mg/day
History or significant gastro-intestinal or colon disease, or colon/intestinal resection
Irritable bowel syndrome
History of breast cancer, or abnormal mammogram within 12 months
History of chronic obstructive pulmonary disease, diabetes mellitus, liver disease or unstable ischemic heart disease
Significant neurological disease other than AD that might affect cognitive function, such as stroke, Parkinson's disease, multiple sclerosis, or serious traumatic brain injury
